openPR Logo
Press release

Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market Latest Trends by 2021

06-19-2018 02:35 PM CET | Energy & Environment

Press release from: Persistence Market Research

Multitargeted Therapies Promiscuous Drugs and Combination

A paradigm shift has been observed with respect to the development of effective therapies involving the use of complementary drug combinations. The main focus of such therapies is to target all the tumor components and impair their function. Tyrosine kinase receptors, mitochondria and microtubule networks are some of the most common targets of cancer cells. This novel approach helps in elucidating the effects of therapeutic combination on each tumor component and results in unveiling of new anti-cancer mechanisms.

These anti-cancer mechanisms in turn pave the path for development of new drugs and strategies to tackle with the condition. Combination therapies are used against complex disorders that have multiple causes along with multiple targets and many small molecule drugs are capable of addressing multiple targets. Multitargeted therapies is the emerging discipline resulting from the combination of chemogenomics and network biology. The market for multitargeted therapies exhibits impressive growth due to effective treatment options, use of small molecule drugs effective against multiple targets and rise in the number of patients suffering from complex diseases such as cancer.

Request for Report Sample: https://www.persistencemarketresearch.com/samples/5567

The market for multitargeted therapies can be segmented on the basis of the molecules used in the treatment and novel approaches towards development of novel combination therapies against multiple targets. Multitargeted protein kinase inhibitors are effective in treating chronic myelogenous leukemia. Synthetic lethality results from the combination of mutations in two or more genes leading to cell death. This approach is adopted to develop targeted therapies in order to reduce the off-target effects due to use of chemopreventative drugs and chemotherapies.

Request for Report TOC: https://www.persistencemarketresearch.com/toc/5567

The major factors driving the growth of the market are constant rise in the number of cancer patients worldwide in conjunction with increasing preference for effective treatment options. In addition, introduction of novel drugs and technological advances will further fuel the market growth. On the contrary, prolonged and tedious development phase followed by high costs of drug development process are some of the factors that might restrain the growth of the market.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market Latest Trends by 2021 here

News-ID: 1088703 • Views:

More Releases from Persistence Market Research

Natural Health Supplements Market to Reach $112.8 Bn by 2032 Driven by Wellness Trends
Natural Health Supplements Market to Reach $112.8 Bn by 2032 Driven by Wellness …
The global natural health supplements market is set for robust expansion, reflecting the world's growing inclination toward wellness, preventive healthcare, and clean-label nutritional products. The market is projected to reach a valuation of US$ 66.7 billion in 2025 and is expected to exhibit a healthy compound annual growth rate (CAGR) of 7.8% during the forecast period from 2025 to 2032. By the end of 2032, the market is anticipated to
Pet Snacks and Treats Market Value to Reach $19.5 Bn by 2030 Driven by Rising Pet Ownership
Pet Snacks and Treats Market Value to Reach $19.5 Bn by 2030 Driven by Rising Pe …
The global pet snacks and treats market is poised for notable growth over the coming years, expanding from a valuation of US$13.3 billion in 2023 to an estimated US$19.5 billion by the end of 2030. The market is forecast to grow at a compound annual growth rate (CAGR) of 5.6% during the period from 2023 to 2030. This consistent growth trajectory is primarily attributed to rising pet ownership rates, increasing
Brewer's Yeast Powder Market Value to Reach US$4.4 Bn by 2031 Driven by Rising Health Awareness
Brewer's Yeast Powder Market Value to Reach US$4.4 Bn by 2031 Driven by Rising H …
The global brewer's yeast powder market is set to experience strong growth over the coming years, expanding from a valuation of US$2.5 billion in 2024 to US$4.4 billion by the end of 2031. This growth represents a robust compound annual growth rate (CAGR) of 8.4% during the forecast period from 2024 to 2031. The rising demand for functional food ingredients, growing health consciousness among consumers, and the expanding applications of
Asparagus Market Growth Driven by Health Trends to Reach US$33.8 Bn by 2030 at 5.2% CAGR
Asparagus Market Growth Driven by Health Trends to Reach US$33.8 Bn by 2030 at 5 …
The global asparagus market is forecast to expand at a steady CAGR of 5.2%, increasing from a value of US$23.7 billion in 2023 to US$33.8 billion by the end of 2030. This growth trajectory is underpinned by the rising global demand for nutrient-rich vegetables and the expanding application of asparagus in culinary and functional food products. The growing health-conscious consumer base, combined with an increasing preference for plant-based and low-calorie

All 5 Releases


More Releases for Multitargeted

ALK-positive Non-Small Cell Lung Cancer Pipeline: Companies Advancing Targeted T …
The therapeutic landscape for ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC), a genetically defined subset of lung cancer driven by ALK gene rearrangements, is undergoing a significant transformation. Biopharmaceutical companies are shifting focus from traditional chemotherapy to precision medicine approaches that directly inhibit ALK-driven oncogenic signaling. With multiple generations of ALK inhibitors now available and resistance mechanisms emerging, the spotlight is on next-generation inhibitors, combination regimens, and CNS-penetrant therapies designed
Liver Cancer Drug Market - A Comprehensive Study by Key Players: Eisai, Exelixis …
Archive Market Research Released the latest study on Global Liver Cancer Drug Market Growth Outlook 2024-2032 provides an opportunity to better understand details about fundamental restructuring and growth prognosis in Online Apparel Market. This study offers current relevant facts and correlations and elaborates long-term, sustainable strategic and operative suggestions taken up by leading and emerging manufacturers. The sector faces an unprecedented change with regard to the far-reaching effects that it
Pheochromocytoma Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updat …
DelveInsight's, "Pheochromocytoma Pipeline Insight, 2023," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Pheochromocytoma pipeline landscape. It covers the Pheochromocytoma pipeline drug profiles, including Pheochromocytoma clinical trials and nonclinical stage products. It also covers the Pheochromocytoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. In the Pheochromocytoma Pipeline Report,
Renal Cell Carcinoma Market Set to Experience Unprecedented Growth During the Fo …
As per DelveInsight, the Renal Cell Carcinoma Market is anticipated to evolve immensely in the coming years owing to the rise in the healthcare spending across the world, the increase in the number of cases of Renal Cell Carcinoma, and the launch of new therapies in the market. DelveInsight's "Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted
Cattle Encephalon Glycoside and Ignotin Injection Market Size, Share 2022, Impre …
The global cattle encephalon glycoside and ignotin injection market is anticipated to grow at a CAGR of 3.4% during the forecast period (2022-2028). Cattle encephalon glycoside and ignotin injection has been widely used in the treatment of central and peripheral nerve injuries. According to WHO, Dementia is a condition in which cognitive performance deteriorates beyond what would be expected as a result of normal biological aging. Dementia is not a
Fecal Analyzer Market Growth Is Driven By Heska Corporation , AVE Science and Te …
A report by The Insight Partner's on the Fecal Analyzer Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market by monitoring the strengths and weaknesses of prominent contributors and their key products. The fecal analyzer market was valued at US$ 657.44million in 2019and is projected to reach US$ 842.48